Target intelligence / Profile preview

Beta-lactamase class D enzyme (None)

Target
None
Molecular classification
Enzyme, Hydrolase, Beta-Lactamase, Class D Beta-Lactamase
01

Overview

Class D β-lactamases, also known as oxacillinases (OXA-type β-lactamases), are a diverse group of serine-dependent enzymes produced by bacteria. They confer resistance to β-lactam antibiotics by hydrolyzing the characteristic four-membered β-lactam ring found in these drugs, thereby inactivating their antibacterial properties. These enzymes are particularly notable for their genetic and biochemical diversity and play a significant role in antibiotic resistance among Gram-negative pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and Proteus mirabilis. A unique feature is a post-translationally carbamylated lysine residue (Lys70 or Lys74), which acts as a general base during catalysis—this modification is critical for enzymatic activity and distinguishes class D from other serine-based classes. The emergence of plasmid-borne OXA-type genes has led to widespread resistance against many frontline antibiotics—including last-resort agents like carbapenems—in major nosocomial pathogens. Their diversity complicates detection and treatment strategies due to variable substrate profiles across different enzyme variants.

Other names
OxacillinaseOXA-type beta-lactamase
02

Mechanism of action

Serine-dependent hydrolysis via nucleophilic attack on beta lactam ring

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam antibiotics
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Widespread antibiotic resistanceEmergence of carbapenem-resistant strainsVariable substrate profiles complicating detection and treatment
06

Interacting drugs

Oxacillin

6 more in the full profile.

Beyond the preview

Go deeper on Beta-lactamase class D enzyme (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase class D enzyme (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call